Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients

Scandinavian Journal of Clinical and Laboratory Investigation
F M YilmazD Yücel

Abstract

Cardiovascular disease (CVD) is the major cause of mortality and morbidity of hemodialysis (HD) and peritoneal dialysis (CAPD) patients. We aimed to investigate the cardiovascular risk factors and their correlation with CVD in groups of HD and CAPD patients. Thirty HD patients, 30 CAPD patients and 30 healthy controls were included in the study. Apolipoprotein A-l (apo A-l), apolipoprotein B (apo B), apolipoprotein(a) [Lp(a)] and high-sensitivity CRP (hs-CRP) were measured with a Beckman Coulter nephelometer, and homocysteine (Hcy) was determined with an Agilent HPLC analyzer. Lipid profile was determined with a Synchron LX 20 Pro analyzer. Hcy levels were 41.9+/-19.4, 41.8+/-38.5 and 9.3+/-3.5 micromol/L; Lp(a) levels were 325+/-315, 431+/-367 and 130+/-97 mg/L; hs-CRP levels were 3.78+/-3.21, 4.34+/-3.39 and 2.07+/-1.67 mg/L; apo A1/apo B ratios were 1.46+/-0.6, 1.36+/-0.5 and 1.80+/-0.59; total cholesterol levels were 3.56+/-0.7, 4.84+/-1.1 and 4.39+/-0.5 mmol/L; triglycerides were 1.44+/-0.5, 1.60+/-0.8 and 0.85+/-0.5 mmol/L in the HD, CAPD and control groups, respectively. HD and CAPD patients had higher Hcy, hs-CRP and Lp(a) levels and lower apo A/B ratios than controls. There was no significant difference between the HD ...Continue Reading

References

Nov 17, 1989·Science·G Utermann
Jul 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·E G LowrieN L Lew
Jan 1, 1996·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·F KronenbergH Dieplinger
Nov 20, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R N FoleyM J Sarnak
Jul 21, 1999·Kidney International. Supplement·H OhashiS Sakata
Aug 18, 1999·Blood Purification·V PanichiR Palla
Feb 29, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J Y YeunG A Kaysen
Feb 13, 2001·Kidney International. Supplement·C van GuldenerC D Stehouwer
May 15, 2001·Laboratory Investigation; a Journal of Technical Methods and Pathology·P DurandD Blache
Sep 20, 2001·Journal of the American Society of Nephrology : JASN·Allon N FriedmanIrwin H Rosenberg
Mar 4, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Mohamed E SulimanBengt Lindholm
Jun 19, 2003·Clinical Chemistry and Laboratory Medicine : CCLM·Hayet FellahAbderraouf Mebazaa

❮ Previous
Next ❯

Citations

Mar 9, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ashok Kumar Yadav, Vivekanand Jha
Jun 30, 2010·Journal of Lipid Research·Tanja X PedersenLars B Nielsen
Jan 14, 2012·Clinical Journal of the American Society of Nephrology : CJASN·Peter Yam-Kau PoonPhilip Kam-Tao Li
Sep 17, 2008·Srpski arhiv za celokupno lekarstvo·Dijana B Jovanović
Feb 7, 2014·Pakistan Journal of Biological Sciences : PJBS·Adel GouriNabila Kouicem
Nov 15, 2007·The Annals of Pharmacotherapy·Melanie S JoyCynthia Denu-Ciocca
Nov 28, 2012·Clinical Chemistry and Laboratory Medicine : CCLM·Marek KolarzMichał Myśliwiec
May 1, 2021·Life·Carlo Maria BarbagalloEmilio Nardi
Sep 16, 2008·Archives of Pathology & Laboratory Medicine·Giuseppe LippiGian Cesare Guidi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.